Kestutis Aukstuolis, DO
Allergy & Immunology · Vienna, VANPI 1831400548
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sanofi accounts for 72.5% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $11,933, more than ten times the $187 reported in 2019.
Across 237 payments — averaging $72.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$13K
- AstraZeneca$2K
- Takeda Pharmaceuticals U.S.A., Inc.$442
- Regeneron Healthcare Solutions, Inc.$436
- GSK$313
- CSL Behring$284
- plus $2K from 21 others
What the payments were for
- Consulting fees$9,98458%
- Travel & lodging$3572%
- Food & beverage$6,89040%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 54 | $12,507 |
| AstraZeneca | 46 | $1,510 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $442 |
| Regeneron Healthcare Solutions, Inc. | 10 | $436 |
| GSK | 15 | $313 |
| CSL Behring | 12 | $284 |
| ARS Pharmaceuticals Operations, Inc. | 22 | $272 |
| Novartis | 11 | $249 |
| Amgen | 12 | $221 |
| Genentech USA, Inc. | 6 | $178 |
| AbbVie | 3 | $135 |
| Biocryst US Sales Co., LLC | 3 | $82 |
| ADMA Biomanufacturing LLC | 3 | $72 |
| Lilly USA, LLC | 3 | $68 |
| Pharming Healthcare, Inc. | 3 | $64 |
| Grifols USA, LLC | 3 | $56 |
| Pfizer | 2 | $49 |
| Incyte Corporation | 2 | $43 |
| Blueprint Medicines Corporation | 1 | $43 |
| Ionis Pharmaceuticals, Inc. | 2 | $40 |
| GC Biopharma USA, Inc. | 1 | $39 |
| Tersera Therapeutics LLC | 1 | $33 |
| Hikma Pharmaceuticals USA | 2 | $30 |
| Alk-abello, Inc | 1 | $25 |
| Shire North American Group Inc | 1 | $21 |
| Organon | 1 | $20 |
| Kaleo, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,251 in reported general payments places this provider in the 80th percentile of 133 allergy & immunology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $62,252 |
| Dupixent SyringeDupilumab | 15 | $54,595 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $21,726 |
| Spiriva RespimatTiotropium Bromide | 16 | $10,175 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $7,953 |
| Epinephrine | 17 | $5,839 |
| DuleraMometasone/Formoterol | 11 | $5,495 |
| Advair HfaFluticasone Propion/Salmeterol | 14 | $4,319 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $3,886 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $3,134 |
| Cromolyn Sodium | 13 | $2,810 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $2,478 |
| Azelastine Hcl | 84 | $2,370 |
| Montelukast Sodium | 77 | $1,025 |
| Fluticasone Propionate | 11 | $383 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $313 | $29,67938 claims |
| Hikma Pharmaceuticals USAEpinephrine | $30 | $5,83917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 133 allergy & immunology providers in Virginia.
Other allergy & immunology in Vienna
- Jacqueline Eghrari-SabetVienna$1M
- Karen KaufmanVienna$13K
- Barbara MackieVienna$11K
- Ahmad HamadVienna$9K
- Sadia Hayat KhanVienna$6K
- Charles LaneLynchburg$1.4M
- Eric KarlinWilliamsburg$522K
- Nicholas RiderRoanoke$227K
- Courtney BlairMc Lean$139K
- Andrew KimFredericksburg$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.